Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment
Science Advances · 14.02.2025 · 11 (7)
DOI: 10.1126/sciadv.adr4333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.02.2025. Verfasst von Peihang Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Extracellular Traps, Myocardial Ischemia, Neutrophils, Sarcoplasmic Reticulum. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Myocardial ischemia-reperfusion injury (MIRI) often leads to irreversible myocardium dysfunction, while existing therapies are palliatives that transiently alleviate the disease symptoms. Repairing sarcoplasmic reticulum Ca 2+ -ATPase (SERCA) could reverse MIRI, which, however, requires precise drug delivery to the sarcoplasmic reticulum (SR). To this end, we leverage cell-cell “NETwork” of neutrophils to deliver SERCA activator-loaded SR-localized nanoparticles (L-P-NPs) to the damaged myocardial cells, following a hierarchical targeting process: (i) chemotactic neutrophils deliver L-P-NPs to ischemia-reperfused heart, achieving tissue level targeting; (ii) neutrophils produce neutrophil extracellular traps (NETs) to transport L-P-NPs to injured myocardial cell, achieving cellular level targeting; (iii) L-P-NPs escort therapeutic payloads to the SR, achieving subcellular targeting. We showed that this platform profoundly restored SERCA activity, augmented cardiac function, and ameliorated adverse heart remodeling. Our study provides insight into the direct restoration of SR for the effective treatment of MIRI and other muscle diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…
- Laboratory of Cardiac Structure and Function, Institute of Cardiovascular Diseases and Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Peihang Jiang, Yudi Deng, Lian Li, Mao Chen, Yuan Huang
Zitieren
APA
Jiang, P., Huang, F., Chen, L., Zhou, H., Deng, Y., Li, L., Chen, M., & Huang, Y. (2025). Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment. Science Advances, 11(7). https://doi.org/10.1126/sciadv.adr4333
Vancouver
Jiang P, Huang F, Chen L, Zhou H, Deng Y, Li L, et al. Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment. Science Advances. 2025;11(7). doi:10.1126/sciadv.adr4333
BibTeX
@article{Jiang2025,
author = {Jiang, Peihang and Huang, Fangyang and Chen, Liqiang and Zhou, Hao and Deng, Yudi and Li, Lian and Chen, Mao and Huang, Yuan},
title = {Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {7},
doi = {10.1126/sciadv.adr4333}
}
EUVIMED